Elisabetta Calistri
- Hematology top 5%
- Oncology
- Genetics top 10%
- Molecular Biology
- Immunology
- Co-authors
- Renato FaninMario TiribelliAntonella GerominAngela MicheluttiDaniela DamianiFrancesco ZajaCristina SkertMichela Cerno
- Topics
- Chronic Myeloid Leukemia Treatments (8 papers)Acute Myeloid Leukemia Research (5 papers)Eosinophilic Disorders and Syndromes (5 papers)
- Cited by
- HematologyGeneticsOncology
- Partner nations
- ItalyUnited States
In The Last Decade
Elisabetta Calistri
14 papers receiving 306 citations
Peers
Comparison fields: 5 of 51
- Hematology 205
- Oncology 111
- Genetics 83
- Molecular Biology 66
- Immunology 65
Countries citing papers authored by Elisabetta Calistri
This map shows the geographic impact of Elisabetta Calistri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabetta Calistri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabetta Calistri more than expected).
Fields of papers citing papers by Elisabetta Calistri
This network shows the impact of papers produced by Elisabetta Calistri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabetta Calistri. The network helps show where Elisabetta Calistri may publish in the future.
Co-authorship network of co-authors of Elisabetta Calistri
This figure shows the co-authorship network connecting the top 25 collaborators of Elisabetta Calistri. A scholar is included among the top collaborators of Elisabetta Calistri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabetta Calistri. Elisabetta Calistri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | SAFETY AND EFFICACY OF RUXOLITINIB (RUX) IN PATIENTS WITH INTERMEDIATE-1-RISK MYELOFIBROSIS (MF) FROM AN OPEN-LABEL, MULTICENTER, SINGLE-ARM EXPANDED-ACCESS STUDY | 5 |
| 6 | 13 | |
| 7 | 7 | |
| 8 | 1 | |
| 9 | 42 | |
| 10 | 6 | |
| 11 | 25 | |
| 12 | 14 | |
| 13 | 99 | |
| 14 | The prognostic value of P-glycoprotein (ABCB) and breast cancer resistance protein (ABCG2) in adults with de novo acute myeloid leukemia with normal karyotype. | 92 |
About Elisabetta Calistri
Elisabetta Calistri is a scholar working on Hematology, Genetics and Rheumatology, having authored 14 papers that have together received 308 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (8 papers), Acute Myeloid Leukemia Research (5 papers) and Eosinophilic Disorders and Syndromes (5 papers). The work is most often cited by research in Hematology (205 citations), Genetics (83 citations) and Oncology (111 citations). Elisabetta Calistri has collaborated with scholars based in Italy and United States. Frequent co-authors include Renato Fanin, Mario Tiribelli, Antonella Geromin, Angela Michelutti, Daniela Damiani, Francesco Zaja, Cristina Skert, Michela Cerno, Francesca Patriarca and Carla Filì. Their work appears in journals such as Blood, International Journal of Biological Macromolecules and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.